Literature DB >> 656285

(+)-Propranolol clearance, an estimation of hepatic blood flow in man.

Y A Weiss, M E Safar, J P Lehner, J A Levenson, A Simon, J M Alexandre.   

Abstract

1 Hepatic blood flow was determined before and during (+)- and (+/-)-propranolol plasma concentration plateaus in 19 patients with suspected renal hypertension and normal liver function. 2 Hepatic blood flow significantly decreased (P less than 0.001) during (+/-)-propranolol administration and remained unchanged during (+)-propranolol administration. 3 Hepatic extraction ratio was 74 +/- 1% (+/-)-propranolol and 79 +/- 2% for (+)-propranolol. 4 Total propranolol clearances were determined during the steady-state achieved by a constant infusion. A highly significant positive relationship was observed (r = +0.86; P less than 0.01) between hepatic blood flow and (+)-propranolol clearance. The slope of the curve was 1.05 +/- 0.27. 5 The result implies that the total clearance of (+)-propranolol constitutes an accurate estimation of basal hepatic blood flow in subjects with normal liver function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656285      PMCID: PMC1429344          DOI: 10.1111/j.1365-2125.1978.tb01655.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  SPLANCHNIC EXTRACTION AND CLEARANCE OF ALDOSTERONE IN SUBJECTS WITH MINIMAL AND MARKED CARDIAC DYSFUNCTION.

Authors:  J F TAIT; B LITTLE; S A TAIT; C FLOOD; J BOUGAS
Journal:  J Clin Endocrinol Metab       Date:  1965-02       Impact factor: 5.958

3.  THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.

Authors:  S E Bradley; F J Ingelfinger; G P Bradley; J J Curry
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

4.  The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.

Authors:  A S Nies; G H Evans; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

7.  Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.

Authors:  R E Stenson; R T Constantino; D C Harrison
Journal:  Circulation       Date:  1971-02       Impact factor: 29.690

8.  [Lectures on liver physiology and physiology. I. Hepatic circulation].

Authors:  J P Benhamou; C Sicot; S Erlinger
Journal:  Presse Med       Date:  1971-01-27       Impact factor: 1.228

9.  Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.

Authors:  Y A Weiss; M E Safar; C Chevillard; A Frydman; A Simon; P Lemaire; J M Alexandre
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

10.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.

Authors:  R A Branch; D G Shand; G R Wilkinson; A S Nies
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

  10 in total
  6 in total

1.  A population study of the pharmacokinetics of felodipine.

Authors:  E Blychert; B Edgar; D Elmfeldt; T Hedner
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

3.  Drug administration and food.

Authors: 
Journal:  Br Med J       Date:  1979-02-03

4.  Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.

Authors:  L A Bauer; K Murray; J R Horn; K Opheim; J Olsen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Physiological and pharmacological variability in estimated hepatic blood flow in man.

Authors:  T K Daneshmend; L Jackson; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

6.  A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.

Authors:  Swan Lin; Jason Gong; George C Canas; Peter Winkle; Kathleen Pelletier; Robert R LaBadie; Katherine Ginman; Yazdi K Pithavala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-01-11       Impact factor: 2.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.